MedTrace Logo

NUTS for the Prevention of Cardiovascular Disease in Chinese Adults

NCT04037943 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2022-08-09

No results posted yet for this study

Summary

This study evaluates the feasibility of walnuts supplementation among population of high CVD risks over a period of 6 months. 70 participants will be controls receiving non-edible gifts. 70 participants will be given 30 grams of walnuts everyday and 70 participants will be given 60 grams of walnuts a day.

Conditions

Interventions

DIETARY_SUPPLEMENT

Walnuts 30 grams

Roasted walnuts without salt or sugar.

DIETARY_SUPPLEMENT

Walnuts 60 grams

Roasted walnuts without salt or sugar.

Sponsors & Collaborators

  • Ningxia Medical University

    collaborator OTHER

  • The George Institute for Global Health, China

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-14
Primary Completion
2020-07-30
Completion
2021-12-24

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04037943 on ClinicalTrials.gov